{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T09:47:39Z","timestamp":1648979259254},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.arcped.2010.10.012","type":"journal-article","created":{"date-parts":[[2010,12,4]],"date-time":"2010-12-04T09:41:09Z","timestamp":1291455669000},"page":"45-48","source":"Crossref","is-referenced-by-count":1,"title":["La maladie de Willebrand de type 2N \u00ab\u00a0Normandie\u00a0\u00bb. \u00c0 propos d\u2019une observation"],"prefix":"10.1016","volume":"18","author":[{"given":"F.","family":"Monpoux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Appert-Flory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2010.10.012_bib0005","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S0929-693X(00)86985-7","article-title":"Exploration des troubles de l\u2019h\u00e9mostase de l\u2019enfant (en dehors de la p\u00e9riode n\u00e9onatale)","volume":"6","author":"Bader-Meunier","year":"1999","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.arcped.2010.10.012_bib0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1055\/s-2007-966977","article-title":"Significance of blood test prior to adenoidectomy","volume":"87","author":"Schwaab","year":"2008","journal-title":"Laryngorhinootologie"},{"key":"10.1016\/j.arcped.2010.10.012_bib0015","series-title":"Disorders of thrombosis and hemostasis","article-title":"Hereditary coagulation protein defects","author":"Nizzi","year":"2002"},{"key":"10.1016\/j.arcped.2010.10.012_bib0020","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V70.4.895.895","article-title":"Von Willebrand factor and von Willebrand disease","volume":"70","author":"Ruggeri","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2010.10.012_bib0025","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2010.10.012_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2516.2009.02005.x","article-title":"Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance","volume":"16","author":"Terraube","year":"2010","journal-title":"Haemophilia"},{"issue":"Suppl. 1","key":"10.1016\/j.arcped.2010.10.012_bib0035","first-page":"52","article-title":"Classification of inherited von Willebrand disease and implications in clinical practice","volume":"124","author":"Federici","year":"2009","journal-title":"Thromb Res"},{"issue":"Suppl. 3","key":"10.1016\/j.arcped.2010.10.012_bib0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2516.2008.01713.x","article-title":"Von Willebrand disease update: diagnostic and treatment dilemmas","volume":"14","author":"Bolton-Maggs","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.arcped.2010.10.012_bib0045","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"6","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2010.10.012_bib0050","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood.V74.5.1591.1591","article-title":"New variant of von Willebrand disease with defective binding to factor VIII","volume":"74","author":"Nishino","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2010.10.012_bib0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood.V75.1.20.20","article-title":"A new von Willebrand factor (vWF) defect in patient with Factor VIII (FVIII) deficiency but with normal level and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF\/FVIII interaction","volume":"75","author":"Mazurier","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2010.10.012_bib0060","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1182\/blood.V77.9.1937.1937","article-title":"The \u00ab\u00a0Normandy\u00a0\u00bb variant of von Willebrand disease: Characterization of a point mutation in the von Willebrand factor gene","volume":"77","author":"Gaucher","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2010.10.012_bib0065","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/beha.2001.0138","article-title":"Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology","volume":"14","author":"Mazurier","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.arcped.2010.10.012_bib0070","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/MBC.0b013e328332d022","article-title":"Identification and prevalence of von Willebrand disease type 2N (Normandy) in Australia","volume":"20","author":"Favaloro","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.arcped.2010.10.012_bib0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01.mbc.0000198048.42634.5a","article-title":"Use of a new enzyme-linked immunosorbent assay for the detection of type 2N von Willebrand disease and its prevalence in an Indian population","volume":"17","author":"Ghosh","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.arcped.2010.10.012_bib0080","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1182\/blood.V97.7.1915","article-title":"How I treat patients with von Willebrand disease","volume":"97","author":"Mannucci","year":"2001","journal-title":"Blood"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X10004604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X10004604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T09:55:50Z","timestamp":1592128550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X10004604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0929693X10004604"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2010.10.012","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}